Study shows concerning levels of COVID-19 vaccine hesitancy

More than a third of people (34%) in Turkey and one sixth of people (17%) in the UK are 'hesitant' about a COVID-19 vaccine, according to a study by UCL and Dokuz Eylul University in Turkey.

The research, published in the journal Psychological Medicine, asked over 5,000 participants in Turkey and the UK about their willingness to vaccinate for a potential COVID-19 vaccine and beliefs on the origin of the novel coronavirus. The findings show concerning levels of COVID-19 vaccine hesitancy.

From an evolutionary point of view, natural selection should favor a bias towards making the least costly decision when there is uncertainty. This is why when people face a choice between taking a specific action or doing nothing, they sometimes prefer to do nothing. This cognitive bias, called the omission bias, may kick in when people make vaccination decisions."

Dr Gul Deniz Salali, Study Lead Author and Evolutionary Anthropologist, UCL

The researchers examined the factors that are associated with acceptance of a COVID-19 vaccine. One of the key factors that explained the probability of vaccine acceptance was a person's belief on the origin of the novel coronavirus.

Odds of vaccine acceptance were 26% higher in Turkey and 63% higher in the UK if a person believed in the natural origin, compared to those who were not sure about the virus origin. In Turkey, participants who believed in the artificial origin of the virus (i.e. SARS-Cov-2 was human-made) were 54% more likely to be vaccine-hesitant.

The research is led by Dr Salali and conducted in collaboration with a social psychology doctoral researcher, Mete Sefa Uysal at Dokuz Eylul University in Turkey.

The study reported several other behavioral and demographic factors that influenced vaccination and origin beliefs. Participants who had higher levels of pandemic related anxieties, such as being more worried about catching or passing on the virus, were more likely to accept COVID-19 vaccination.

Compared to women, men in Turkey were more likely to accept a COVID-19 vaccine and believe in the natural origin of the virus.

Dr Salali said "From an evolutionary perspective, emotions can be seen as detectors helping us to avoid death or promote reproduction, especially under uncertainty. The positive correlation between COVID-19 related anxiety and vaccine acceptance can be rooted in the adaptive function of anxiety in decreasing mortality risk."

"Because women are more likely to take healthcare decisions for their children, they may also be more likely to seek out information about vaccines and be exposed to online anti-vaccination content. Moreover, women score higher on disgust sensitivity which is associated with vaccine hesitancy."

Much research effort is focused on developing an effective vaccine for combating COVID-19. Vaccine development itself, however, will not be enough given that a sufficient amount of people will need to be vaccinated for widespread immunity.

The study findings point at a concerning level of COVID-19 vaccine hesitancy, especially in Turkey, and suggest that wider communication of the scientific consensus on the origin of the novel coronavirus with the public may help future campaigns targeting COVID-19 vaccine hesitancy.

Source:
Journal reference:

Salali, G D & Uysal, M S (2020) COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychological Medicine. doi.org/10.1017/S0033291720004067.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Argonne receives $21.7 million to advance cancer and vaccine discoveries